Checking how well transplanted islet cells work in chronic pancreatitis
Part of Digestive system clinical trials.
This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis, and you are scheduled for TP alone or TP with islet transplantation (TP-AIT)
- You are 18 years old or older
- You can and are willing to return for required follow-up visits at Baylor
- If you are getting TP-AIT, your pancreas disease must not be too advanced, based on chart and test review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a surgery that removes the entire pancreas and then transplants your own insulin-making cells (islet cells) back into your liver. It aims to relieve chronic pancreatitis pain while reducing the risk of diabetes.
This study collects health information and samples from people with chronic pancreatitis over time. It aims to better understand the disease and improve care for future patients.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
This study checks how well transplanted islet cells are working over time and monitors long-term safety. If you previously received an islet transplant and are still using medicine to prevent rejection, you may be followed again.
This study follows people over the long term after their islet transplant fully stops working. It aims to learn what happens after complete graft loss and monitor health outcomes over time.
This study tests a way to check and improve the health of insulin-making cells before they are transplanted into people with type 1 diabetes. The goal is to make the transplant more likely to work and last longer.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.